Novartis Ag (NVSEF) EBIT Margin Growth (5y) (2014 - 2025)

Novartis Ag (NVSEF) EBIT Margin Growth (5y) (2014 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Novartis Ag - - -

Historic Data

Download Data
DateValue
Jun 30, 2025 10,509.00
Jun 30, 2024 944.00
Dec 31, 2023 -77,823.00
Jun 30, 2023 566.00
Mar 31, 2023 154.33 Mn
Dec 31, 2022 750,743.00
Sep 30, 2022 -58,306.00
Jun 30, 2022 10,197.00
Mar 31, 2022 -45,623.00
Dec 31, 2021 2,167.00
Sep 30, 2021 -39,150.00
Jun 30, 2021 -83,042.00
Mar 31, 2021 -17.81 Bn
Dec 31, 2020 710,654.00
Sep 30, 2020 30,336.00
Jun 30, 2020 -21,754.00
Mar 31, 2020 -24,550.00
Jun 30, 2019 -49,578,947.37 Bn
Mar 31, 2019 -168,624.00
Jun 30, 2018 -43,295.00